Stock ALMDP MEDESIS PHARMA S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Company Medesis Pharma S.A.

Equities

ALMDP

FR0010844464

Biotechnology & Medical Research

Market Closed - Euronext Paris
Other stock markets
 08:19:25 2024-04-26 am EDT 		5-day change 1st Jan Change
1.4 EUR -2.10% Intraday chart for Medesis Pharma S.A. -10.83% +61.29%
2023 Medesis Pharma S.A. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
2023 MEDESIS : Invest Securities confirms its recommendation CF

Business Summary

Medesis Pharma S.A. is specialized in the research and development, based on a breakthrough technology (AONYS®) for the delivery of therapeutic molecules, of drugs to treat diseases for which there is no effective treatment.

The company's portfolio includes a drug candidate used to optimize cancer radiotherapy, 2 drug candidates used in the treatment of neurodegenerative diseases (Alzheimer's disease and Huntington's disease) and 2 drug candidates used in the treatment of radioactive contamination following a civil or military nuclear accident (Plutonium decorporation and cesium decorporation).

Number of employees: 10

Sales per Business

EUR in Million2019Weight2020Weight Delta
Biopharmaceutical
100.0 %
0 100.0 % 0 100.0 % -9.35%

Sales per region

EUR in Million2019Weight2020Weight Delta
France
100.0 %
0 100.0 % 0 100.0 % -9.35%

Managers

Managers TitleAgeSince
Jean-Claude Maurel CEO
 Chief Executive Officer - 03-04-02
Solene Guilliot CTO
 Chief Tech/Sci/R&D Officer - 20-12-31
Mario Alcaraz SEC
 Corporate Secretary - -

Members of the board

Members of the board TitleAgeSince
Bernard Connes-Lafforet BRD
 Director/Board Member - 19-06-11
Robert Alonso BRD
 Director/Board Member - 22-10-26
Walt Linscott BRD
 Director/Board Member 63 22-10-26
Olivier Connes CHM
 Chairman - 18-09-25
Jean-Marie Cazaledes BRD
 Director/Board Member - 15-06-29
Cédric Navas BRD
 Director/Board Member - 18-09-25
Emmanuel Hebert BRD
 Director/Board Member - 19-06-11
Jean-Philippe Causse BRD
 Director/Board Member - 21-06-14

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 4,429,081 3,586,229 ( 80.97 %) 0 80.97 %

Shareholders

NameEquities%Valuation
Friedland Gestion SAS
0.1355 %
6,000 0.1355 % 9 882 €

Company contact information

Medesis Pharma SA

L'Orée des Mas avenue du Golf

34670, Baillargues

+33 4 67 03 03 96

http://www.medesispharma.com
address Medesis Pharma S.A.(ALMDP)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Therapeutic Drugs

Sector Bio Therapeutic Drugs

1st Jan change Capi.
MEDESIS PHARMA S.A. Stock Medesis Pharma S.A.
+61.29% 6.62M
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
-2.31% 103B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+0.56% 95.28B
ARGENX SE Stock argenx SE
+1.69% 22.15B
BIONTECH SE Stock BioNTech SE
-17.37% 21.02B
GENMAB A/S Stock Genmab A/S
-9.30% 18.15B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-41.01% 16.73B
BEIGENE, LTD. Stock BeiGene, Ltd.
-14.85% 16.05B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+3.21% 13.68B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+33.54% 12.17B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. ALMDP Stock
  4. Company Medesis Pharma S.A.